@article{JTD1601,
author = {Michael Fay and Christopher M. Poole and Gary Pratt},
title = {Recent advances in radiotherapy for thoracic tumours},
journal = {Journal of Thoracic Disease},
volume = {5},
number = {Suppl 5},
year = {2013},
keywords = {},
abstract = {Radiation Oncology technology has continued to advance at a rapid rate and is bringing significant benefits to patients. This review outlines some of the advances in technology and radiotherapy treatment of thoracic cancers including brachytherapy, stereotactic radiotherapy, tomotherapy and intensity modulated radiotherapy. The importance of functional imaging with PET and management of movement are highlighted. Most of the discussion relates to non-small cell lung cancer but management of mesothelioma and small cell lung cancer are also covered. This technology has substantial benefits to patients in terms of decreasing toxicity both in the short and longer term.
Radiation Oncology has always been a technology driven specialty, with the rate of advancement steadily increasing. The last few years in particular have seen technology have more of an impact on lung cancer treatment where two major themes have emerged. Firstly improved imaging (especially molecular imaging) and secondly management of movement of both the tumour and organs at risk. Most of the current research effort is focussed on the treatment of non-small cell lung cancer.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/1601}
}